Condition
Alzheimer Dementia clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Alzheimer Dementia clinical trials that are recruiting, at sites in 5 countries (most in United States (3), China (2), United Kingdom (1)). By phase: Phase 2/3 (1), Phase 2 (1), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Alzheimer Dementia clinical trials
All recruiting trials (8)
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Low-Dose Radiation Therapy to See if It Helps Alzheimer's and Inflammatory Dementias
Researchers will test whether giving small amounts of whole-brain radiation over a short course, then monthly boosts for a year, is tolerable and safe in people over 50 with Alzheimer's or dementia with inflammatory features.
-
Brain stimulation plus methylphenidate for apathy in Alzheimer's
This trial will test whether combining short sessions of noninvasive brain stimulation (intermittent theta burst) with methylphenidate can reduce apathy in people with Alzheimer's disease or mixed Alzheimer's/vascular dementia.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Using a blood test to detect Alzheimer's in hospitalized older adults with sudden confusion
This will test whether the Quest AD-Detect blood test can identify underlying Alzheimer's disease in hospitalized patients aged 60–90 who have new confusion, delirium, or encephalopathy.
-
How environmental pollutants relate to brain tumours, stroke, and Alzheimer's
This study will see if exposure to environmental pollutants is linked to brain tumours, cerebrovascular disease, and Alzheimer dementia in consenting adults, particularly those treated by neurosurgery.
-
Huperzine A in mild-to-moderate Alzheimer’s dementia: dosing and safety in a multi-center study
This study tests different doses of huperzine A controlled-release tablets, with a comparison to donepezil and placebos, in adults with mild-to-moderate Alzheimer’s disease to see how well it works and how safe it is.
-
Stimulating the immune system to treat early Alzheimer's disease
This study is testing a new treatment to see if it can safely boost the immune system in older adults with early Alzheimer's disease or mild cognitive impairment.
Related topics
Quick answers
How many Alzheimer Dementia clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), China (2 trials), United Kingdom (1 trial), Canada (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 2: 1, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.